Skip to search formSkip to main contentSkip to account menu

MS-551

Known as: MS 551 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2001
2001
Nifekalant hydrocholoride, a novel class III antiarrhythmic agent, was used as the treatment in 4 patients with extensive… 
1998
1998
We investigated the proarrhythmic effects of MS‐551 and KCB‐328, class III antiarrhythmic drugs using adrenaline‐induced… 
1998
1998
The effects of intravenous MS-551, a new class III antiarrhythmic drug, on atrium and ventricle were evaluated in 6 patients with… 
1996
1996
Dofetilide, a new class III antiarrhythmic agent, was tested in various kinds of canine ventricular arrhythmias to compare its… 
1995
1995
Summary We studied the electrophysiologic and anti-fibrillatory properties of MS-551 (l,3-dimethyl-6-{(2-[N-hydroxy-ethyl)-3-(4… 
Highly Cited
1995
Highly Cited
1995
BACKGROUND It is well known that vagal stimulation increases the vulnerability to atrial fibrillation via muscarinic receptor… 
1994
1994
Summary We studied the electrophysiologic and anti-fibrillatory effects of the class III agent MS-551 in a rabbit isolated heart…